1. Kim, Seongryong, Leem, Galam, Choi, Junjeong, Bang, Seungmin, Park, Jong-Eun. 2024. Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis. In Genome medicine, 16, 20. doi:10.1186/s13073-024-01287-7. https://pubmed.ncbi.nlm.nih.gov/38297291/
2. Yang, Yueli, Jia, Wenqi, Luo, Zhiwei, Mazid, Md Abdul, Li, Wenjuan. 2024. VGLL1 cooperates with TEAD4 to control human trophectoderm lineage specification. In Nature communications, 15, 583. doi:10.1038/s41467-024-44780-8. https://pubmed.ncbi.nlm.nih.gov/38233381/
3. Gemma, Carolina, Lai, Chun-Fui, Singh, Anup K, Buluwela, Laki, Ali, Simak. . Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer. In Cancer research, 84, 4283-4297. doi:10.1158/0008-5472.CAN-24-0013. https://pubmed.ncbi.nlm.nih.gov/39356622/
4. Mori, Seiichiro, Takeuchi, Takamasa, Ishii, Yoshiyuki, Kukimoto, Iwao. 2020. The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1. In Journal of virology, 94, . doi:10.1128/JVI.01945-19. https://pubmed.ncbi.nlm.nih.gov/32132238/
5. Castilla, María Ángeles, López-García, María Ángeles, Atienza, María Reina, Calcabrini, Annarica, Palacios, José. 2014. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer. In Endocrine-related cancer, 21, 587-99. doi:10.1530/ERC-13-0485. https://pubmed.ncbi.nlm.nih.gov/24891455/
智鼠故事 
